| INFARMED [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products]. | Neurológico
> Esclerose múltipla | Parceria regulatória
> A trabalhar com organismos reguladores | 1000 | National | Regularly | 115015053859 |
| We are partners in the Projeto Incluir [Inclusion Project] led by Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products]. | Cancro
> Cancro: mama | Parceria regulatória
> A trabalhar com organismos reguladores | 1000 | Regional | Regularly | 115017018417 |
| We would, however, welcome a closer relationship with the regulatory authorities. We have already sought to engage with the European medicines regulatory body. | Perda Auditiva
> Perda auditiva | Parceria regulatória
> A trabalhar com organismos reguladores | 100 | National | No | 115029020137 |
| Member of an Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] panel. | Cerebrovascular
> Traço | Parceria regulatória
> A trabalhar com organismos reguladores | 5000 | National | Regularly | 115032426383 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | Defesa do doente
> Defesa do doente | Parceria regulatória
> A trabalhar com organismos reguladores | 5000 | National | Rarely | 115033491291 |
| FamiliarMente sits on the following advisory boards and committees: the National Council for Mental Health and the Regional Councils for Mental Health; the Infarmed [Instituto Nacional de Autoridade do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] Medicines Availability Management Monitoring Committee; and the Monitoring Committee for the Implementation of the Legal Framework for Involuntary Treatment (Mental Health Act), among others. | Saúde mental
> Saúde mental: a maioria das condições | Parceria regulatória
> A trabalhar com organismos reguladores | 10 000 | National | Regularly | 115056273634 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | Defesa do doente
> Defesa do doente | Parceria regulatória
> Participar em avaliações de Avaliação de Tecnologias de Saúde (ATS) e de reembolso | 5000 | National | Rarely | 115033491291 |
| We occasionally receive a form through which we are invited to submit written contributions to HTA [Avaliação de Tecnologias de Saúde – Health Technology Assessment] processes. | Reumático
> Doenças reumáticas: a maioria dos tipos | Parceria regulatória
> Participar em avaliações de Avaliação de Tecnologias de Saúde (ATS) e de reembolso | 100 | National | Sometimes | 115060632863 |
| We participate in the medicines evaluation process at the request of INFARMED [Instituto Nacional da Farmácia e do Medicamento – National Authority of Medicines and Health Products]. | Neurológico
> Esclerose múltipla | Parceria regulatória
> Participar em avaliações de Avaliação de Tecnologias de Saúde (ATS) e de reembolso | 5000 | National | Regularly | 115060898897 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | Defesa do doente
> Defesa do doente | Parceria regulatória
> Contribuir para submissões de Autorização de Introdução no Mercado | 5000 | National | Rarely | 115033491291 |
| We would, however, welcome a closer relationship with the regulatory authorities. We have already sought to engage with the European medicines regulatory body. | Perda Auditiva
> Perda auditiva | Parceria regulatória
> Participar/facilitar reuniões com decisores políticos/reguladores | 100 | National | No | 115029020137 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | Defesa do doente
> Defesa do doente | Parceria regulatória
> Participar/facilitar reuniões com decisores políticos/reguladores | 5000 | National | Rarely | 115033491291 |
| We participate in the medicines evaluation process at the request of INFARMED [Instituto Nacional da Farmácia e do Medicamento – National Authority of Medicines and Health Products]. | Neurológico
> Esclerose múltipla | Parceria regulatória
> Participar/facilitar reuniões com decisores políticos/reguladores | 5000 | National | Regularly | 115060898897 |
| Negotiation with the government or with parliamentary groups. | Saúde geral
> Obesidade | Impacto nas políticas e legislação
> Influenciar a política e legislação de saúde | 1000 | National | Regularly | 115006675660 |
| Engagement activities have included hearings with parliamentary groups, open letters, press releases, and participation in the organisation of research studies. | Respiratório
> Asma | Impacto nas políticas e legislação
> Participar em audiências públicas e consultas | Do not know | National | Sometimes | 115032964525 |
| Engagement activities have included hearings with parliamentary groups, open letters, press releases, and participation in the organisation of research studies. | Respiratório
> Asma | Impacto nas políticas e legislação
> Participar em audiências públicas e consultas | Do not know | National | Sometimes | 115032964525 |
| 2023: meeting with the Parliamentary Health Group at the AR [Assembleia da República – Assembly of the Republic]. | Cardiovascular
> Doenças cardiovasculares & cardíacas | Impacto nas políticas e legislação
> Participar em audiências públicas e consultas | 1000 | National | Sometimes | 115054128784 |
| Negotiation with the government or with parliamentary groups. | Saúde geral
> Obesidade | Impacto nas políticas e legislação
> Mobilizar parlamentares e líderes políticos | 1000 | National | Regularly | 115006675660 |
| Each year, we submit our advocacy document to the parliamentary groups. | Deficiência
> Deficiência: a maioria dos tipos | Impacto nas políticas e legislação
> Mobilizar parlamentares e líderes políticos | We do not communicate with patients directly | National | Regularly | 115006736449 |
| Through the Parliamentary Health Group. | Cardiovascular
> Doenças cardiovasculares & cardíacas | Impacto nas políticas e legislação
> Mobilizar parlamentares e líderes políticos | 100 | National | Regularly | 115033109950 |
| Each year, we submit our advocacy memorandum to the parliamentary groups. This year's submission included a call for the free-of-charge provision of medicines and medical devices for persons with disabilities. | Deficiência
> Deficiência: a maioria dos tipos | Defesa de preços e acessibilidade financeira
> Defender preços justos para medicamentos | We do not communicate with patients directly | National | Regularly | 115006736449 |
| Each year, we submit our advocacy memorandum to the parliamentary groups. This year's submission included a call for the free-of-charge provision of medicines and medical devices for persons with disabilities. | Deficiência
> Deficiência: a maioria dos tipos | Defesa de preços e acessibilidade financeira
> Abordar as barreiras de custo para pessoas de baixo rendimento e vulneráveis | We do not communicate with patients directly | National | Regularly | 115006736449 |
| Active participation in discussions on access to PAP [Programas de Acesso Precoce – Early Access Programmes] and in the centralised funding of medicines intended for rare diseases. | Neuromuscular
> Doenças neuromusculares: a maioria dos tipos | Melhorar os caminhos de acesso
> Melhorar o acesso a terapias raras/ultra-raras | 1000 | National | Regularly | 115022855373 |
| Questionnaire for the collection of contributions from patient associations in the context of Health Technology Assessment [in Portugal]. | Gastrointestinal
> Gastrointestinal: outro | Contribuição do doente baseada em evidências
> Realizar inquéritos/pesquisas para gerar dados | 1000 | National | Sometimes | 114997613546 |
| Engagement activities have included hearings with parliamentary groups, open letters, press releases, and participation in the organisation of research studies. | Respiratório
> Asma | Contribuição do doente baseada em evidências
> Realizar inquéritos/pesquisas para gerar dados | Do not know | National | Sometimes | 115032964525 |
| Member of an Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] panel. | Cerebrovascular
> Traço | Governação institucional
> Garantir representação nos órgãos consultivos governamentais | 5000 | National | Regularly | 115032426383 |
| Projeto Incluir [The project establishes a formal mechanism for patient rights and civic participation in Portugal. It allows patients and their advocacy organizations to have an active voice in Health Technology Assessment (HTA), Medicine Shortages & Safety and Policy Representation: Acting as a bridge between policymakers and citizens, ensuring that healthcare decisions account for patient values and experiences.] | Defesa do doente
> Direitos do doente | Governação institucional
> Garantir representação nos órgãos consultivos governamentais | 5000 | National | Regularly | 115042989304 |
| FamiliarMente sits on the following advisory boards and committees: the National Council for Mental Health and the Regional Councils for Mental Health; the Infarmed [Instituto Nacional de Autoridade do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] Medicines Availability Management Monitoring Committee; and the Monitoring Committee for the Implementation of the Legal Framework for Involuntary Treatment (Mental Health Act), among others. | Saúde mental
> Saúde mental: a maioria das condições | Governação institucional
> Garantir representação nos órgãos consultivos governamentais | 10 000 | National | Regularly | 115056273634 |
| Through the Parliamentary Health Group. | Cardiovascular
> Doenças cardiovasculares & cardíacas | Governação institucional
> Trabalhar eficazmente em redes com múltiplos intervenientes | 100 | National | Regularly | 115033109950 |
interações
ações & defesa
13 menções
